'Scleroderma' diaporamas de présentation

SYSTEMIC CONNECTIVE TISSUE DISEASES

SYSTEMIC CONNECTIVE TISSUE DISEASES. DR CB NEL. INTRODUCTION. Multiple body systems involved Wide spectrum of clinical manifestations Aetiology is multifactorial. SYSTEMIC LUPUS ERYTHEMATOSUS. SLE. Predominantly females, 9:1 ratio Peak onset second and third decades

1.26k views • 50 slides

Andre bindevevssykdommer

665 views • 50 slides

Case Presentation

Case Presentation. Soniya hanif Wayne state university/ Henry Ford Medical Center. 61 year old gentleman Presented at VA inpatient unit CC: dizziness, lightheadedness and inability to swallow solid food. HPI:

397 views • 39 slides

SCLERODERMA

SCLERODERMA. Virginia Steen, MD Professor of Medicine. Scleroderma. Localized Scleroderma Morphea Linear Scleroderma En Coup de Sabre (Progressive Hemi-atrophy) Pansclerotic, Deep subcutaneous. Linear Scleroderma. Hyperpigmented, Muscle atrophy but normal strength.

1.49k views • 33 slides

Future Directions in Treatment of Systemic Sclerotic Complications

430 views • 33 slides

SCLERODERMA

SCLERODERMA. Virginia Steen, MD Professor of Medicine. Scleroderma. Localized Scleroderma Morphea Linear Scleroderma En Coup de Sabre (Progressive Hemi-atrophy) Pansclerotic, Deep subcutaneous. Linear Scleroderma. Hyperpigmented, Muscle atrophy but normal strength.

434 views • 33 slides

CTD objectives

CTD objectives. Know why CTDs are considered autoimmune diseases Know what the epidemiology of CTDs implies about their pathophysiology Understand the concept of disease criteria Know the criteria for SLE and SSc Consider the role of immune pathways in autoimmune disease pathogenesis

602 views • 32 slides

Eduardo P. Manrique M.D.

444 views • 30 slides

AUTOIMMUNE DISEASES

AUTOIMMUNE DISEASES. Ass. Sklyannaya E.V. SYSTEMIC LUPUS ERYTHEMATOSUS. Systemic lupus erythematosus (SLE) is an autoimmune disease in which organs, tissues, and cells undergo damage mediated by tissue-binding autoantibodies and immune complexes. Epidemiology.

466 views • 30 slides

Scleroderma Diagnostics and Therapeutics Market Analysis, Growth Prospect and Applications till 2022

Scleroderma is also termed as systemic sclerosis (SSc), is a chronic, autoimmune disease characterized by structural and functional abnormalities of production of autoantibodies, small blood vessels, and fibrosis of the skin and internal organs. The diagnosis of scleroderma is based on the clinical appearances of the illness. Whereas, treatment is directed toward the individual features affecting different areas of the body.

91 views • 5 slides

Treatment of scleroderma with para-aminobenzoic acid: effect on disease morbidity

This is an expedited review of literature that dives into the less well-known aspects of Scleroderma, also known as systemic sclerosis. Scleroderma is an autoimmune chronic systemic inflammatory disorder of the connective tissue that is characterized by collagen deposition in the skin and other internal organs. The incidence of scleroderma in the United States is approximately 20 cases per million per year while the estimated prevalence is 240 cases per million. The incidence is higher in African Americans and more prevalent in women than in men (4.6:1). Although the etiology of scleroderma is not well identified, exposure to environmental factors, including viruses, certain toxins or drugs, may provoke the disease in genetically susceptible hosts.

46 views • 4 slides

Scleroderma

Scleroderma. Tyler Finders. What it is. Scleroderma is a widespread connective tissue disease that involves changes in the skin, blood vessels, muscles, and internal organs . It is a chronic auto immune disease. Symptoms. Hair loss Skin hardness Skin is abnormally dark or light

293 views • 3 slides